Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 28. April 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8890  Previews Next
   
   Articles 1 - 20 / 177798  
   
Predicting the upgrading of the International Society of Urological Pathology Grade Group in nonclinically significant prostate cancer: a multicenter observational study.
Asian J Androl
Zhou L, Li SY, Wang ZY, Liu YY, Chen C, Yu H.
PMID: 42046346 [PubMed - as supplied by publisher]


Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer.
Proteomics
Ahangar M, Mischak H, Moulavasilis N, Stravodimos K, Mahjoubi F, Jankowski J, Frantzi M, Vlahou A.
PMID: 42046269 [PubMed - as supplied by publisher]


Evaluation of prostate cancer diagnosis during the COVID-19 crisis in the French Caribbean.
Sci Rep
Beaubrun-Renard M, Ulric-Gervaise S, Macni J, Puello A, Cabie A, Joachim C.
PMID: 42045399 [PubMed - as supplied by publisher]


Self-Assembled DNA Nanoladder-Based Electrochemical Biosensor for Rapid and Sensitive Detection of Bladder Tumor-Related miRNA in Urine.
Anal Chem
Wang J, Liu J, Wang Y, Yan W, Sun H, Liu S, Tan Y, Huang J.
PMID: 42045126 [PubMed - as supplied by publisher]


The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancer.
BMJ Open
Hayhurst W, Uribe-Lewis S, Uribe J, Mikropoulos C, Otter S, Goh C, Mehta S, Wood K, Deering C, Higgins D, Langley S, Long M, Michael A, Langley S, Perna C.
PMID: 42044963 [PubMed - indexed for MEDLINE]


Important Role of Ultrasound in Assessing Tubulocystic Renal Cell Carcinoma.
Ultrasound Q
Choi R, Radzinsky E, Morgan T, Fananapazir G.
PMID: 42044518 [PubMed - indexed for MEDLINE]


Life expectancy estimation in older men using the prostate cancer comorbidity index in VA & SEER-Medicare cohorts.
Age Ageing
Heard J, Luu M, Thomas IC, Leppert J, Daskivich T.
PMID: 42043951 [PubMed - indexed for MEDLINE]


Correction: UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL family.
Mol Biomed
Zhang M, Li J, Liu S, Zhou F, Zhang L.
PMID: 42043492 [PubMed - in process]


Classifying Kidney Tumor via Adaptive SE-ResNeXt With Mutli-Novel Loss Function and Renal Mass Segmentation Using Pyramidal Attention-Based R2Unet++ Model.
J Biochem Mol Toxicol
Jayasingh BB, Infantia HN, Panse T.
PMID: 42043283 [PubMed - indexed for MEDLINE]


Post-diagnostic Inflammatory and Insulinemic Diet and Lifestyle Patterns and Risk of Prostate Cancer-Specific Mortality in the Health Professionals Follow-up Study.
Cancer Epidemiol Biomarkers Prev
Graff RE, Pace WA, Kenfield SA, Van Blarigan EL, Langlais CS, Ma C, Stopsack KH, Stampfer MJ, Giovannucci EL, Mucci LA, Tabung FK, Chan JM.
PMID: 42043179 [PubMed - as supplied by publisher]


Serum Untargeted Metabolomics Integrated with SHAP-Based Machine Learning for Multiclass Stratification of Prostate Cancer, Prostatitis, and Benign Prostatic Hyperplasia.
Metabolites
Wang Z, Xin J, He Q, Xu S, Wu J, Yang F, Dong L.
PMID: 42042882 [PubMed]


Omitting Elective Pelvic Nodes Irradiation in High Risk Prostate Cancer: Report on 43 Consecutive Elderly Patients.
J Pers Med
Chioccola E, Caroprese M, Goodyear CA, Barillaro A, Valerio G, Oliviero C, Buono M, Clemente S, Farella A, Conson M, Pacelli R.
PMID: 42042544 [PubMed]


Recurrence Rate After Post-Operative Two-Hour Continuous Bladder Irrigation for Primary Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study.
J Pers Med
Sterner P, Gimbergsson S, Johansson M, Alamdari F, Sherif A, Chabok A, Styrke J.
PMID: 42042542 [PubMed]


A Rare Case of Descending Colon Metastasis Following Radical Nephroureterectomy for Left Ureteral Carcinoma: A Case Report and Literature Review.
Curr Oncol
Zhang H, Liu H, Luo Y, Li P, Yang L, Shi J, Duan J, Yan Y.
PMID: 42041754 [PubMed - indexed for MEDLINE]


Radiotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: Current Evidence and Future Directions.
Curr Oncol
Resende Salgado L, Zaytoun O, Rabie A, Murphy N, Nehlsen A, Hsieh K, Dovey Z, Aamir A, Sindhu KK.
PMID: 42041744 [PubMed - indexed for MEDLINE]


Diagnostic and Clinical Impact of Imaging Modality on PSA Density: TRUS Versus MRI in Gray-Zone Prostate Cancer.
Curr Oncol
Capkan DU, Solakhan M.
PMID: 42041740 [PubMed - indexed for MEDLINE]


The Benefits and Harms of Screening for Prostate Cancer in Adults Aged 18 Years and Older: A Systematic Review.
Curr Oncol
Bennett A, Vyas N, Shaver N, Almoli F, Kibret T, Loblaw A, Del Giudice L, Yao X, Skidmore B, Brouwers M, Little J, Moher D.
PMID: 42041720 [PubMed - indexed for MEDLINE]


Wilms Tumor with Inferior Vena Cava Thrombus: Comparative Analysis of Clinical Characteristics and Outcomes.
Curr Oncol
Al-Hasan R, Al-Qawabah R, Ghandour K, Ibrahimi AK, Sarhan N, Sultan I, Halalsheh H.
PMID: 42041717 [PubMed - indexed for MEDLINE]


Percutaneous Image-Guided Non-Target Renal Biopsy in Cancer Patients: A Tertiary Cancer Center Experience.
Curr Oncol
Abdelsalam ME, Patel MN, Murray RD, Aziz SK, Shields H, Chien P, Yevich S, Metwalli ZA, Wang Z, Lin JS, Huang SY, Irwin D, Lu T, Lee SR, Abudayyeh A, Habibollahi P, Odisio BC, Ahrar K, Gupta S.
PMID: 42041711 [PubMed - indexed for MEDLINE]


Integrative Computational Approaches to Prostate Cancer with Conditional Reprogramming and AI-Driven Precision Medicine.
Cells
Fadiel A, Malpani P, Eichenbaum KD, Naftolin F, Hassouneh A, Chong G, Odunsi K.
PMID: 42041568 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 177798    Page 1 of 8890  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1